Competitive Landscape of Anticancer Drugs Global Market 2019 : Targeted Therapy Drug Class Anticipated to Exhibit Highest Revenue Contribution Through 2026
Press Release – 29
Jan 2019
Research
and Development News
--
.
.
Latest
Update
"Global Market Study on Anticancer Drugs: Targeted Therapy Drug
Class Anticipated to Exhibit Highest Revenue Contribution Through
2026"
with Industries Survey | Global Current Growth and Future.
'
'
The global anticancer drugs market is expected to
yield impressive gains owing to the increasing prevalence of cancer.
According to the World Health Organization, the number of global
cancer deaths is projected to increase by 45% by 2030, with 70% of
the cancer deaths expected to occur in low and middle income
countries. Mortality from cancer is projected to reach over 13
million in 2030, while, the number of new cancer cases is expected to
increase more than 80% in low-income countries, almost double the 40%
rate anticipated in high-income countries by 2030.
'
'
The global
anticancer drugs market has witnessed a paradigmatic shift from
administering highly toxic drugs to targeted personalized therapy
with lower side effects. There is an upsurge in adoption of biologics
especially monoclonal antibodies. New drug development has achieved
high importance owing to emergence of difficulties to treat cancers
such as small cell lung cancer. The increase in the number of
clinical trials coupled with the growing research and development
expenditures has resulted in an buildup of impressive new drug
pipeline, which is expected to confer large future market equity for
the global anticancer drugs market.
The improvement in the survival rate of cancers, e.g., prostrate and breast, is expected to increase the adoption of cancer treatment, which consequently is expected to drive the growth of the global anticancer drugs market. However, lung cancer is expected to be the single large and most attractive market opportunity owing to its large diseases prevalence and poor patient survival rates especially in the advanced stages. The market for global anticancer drugs is also being driven by the advancements in diagnostics and the growing screening rates. Early detection has been the historical holy grail of cancer treatment owing to its impact on survival rates. Advancements and availability of diagnostics such as computed tomography, nuclear medicine are also expected to fuel revenue growth of the anticancer drugs market.
The improvement in the survival rate of cancers, e.g., prostrate and breast, is expected to increase the adoption of cancer treatment, which consequently is expected to drive the growth of the global anticancer drugs market. However, lung cancer is expected to be the single large and most attractive market opportunity owing to its large diseases prevalence and poor patient survival rates especially in the advanced stages. The market for global anticancer drugs is also being driven by the advancements in diagnostics and the growing screening rates. Early detection has been the historical holy grail of cancer treatment owing to its impact on survival rates. Advancements and availability of diagnostics such as computed tomography, nuclear medicine are also expected to fuel revenue growth of the anticancer drugs market.
– For
Other Requirement and Enquiry_
https://www.researchmoz.us/enquiry.php?type=E&repid=1935267
'
'
The Global
Anticancer Drugs Market has been Segmented Based on:
- Drug Class
- Indications
- Distribution Channels
- Regions
- Drug Class
- Indications
- Distribution Channels
- Regions
The report
analyzes the global anticancer drugs market in terms of value (US$
Mn). The report begins with the market definition and explaining
different types of drug class and indications for their use. This
section also explains the prevalence of different types of cancers
across the key regions. The market view point section includes PMRs
analysis on the key trends, drivers, opportunities, trends and macro
factors influencing the global anticancer drugs market. Opportunity
analysis provided in the section allows clients to better equip with
crystal clear decision-making insights.
The report analyzes the anticancer drugs market based on regions and presents the forecast in terms of value (US$ Mn) for the next 08 years. The regions covered in the report include:
The report analyzes the anticancer drugs market based on regions and presents the forecast in terms of value (US$ Mn) for the next 08 years. The regions covered in the report include:
- North
America
- Latin
America
- Europe
-
Asia-Pacific Excluding Japan
- Middle
East & Africa
- Japan
Each of the
section analyzes the regional market by drug class, indications and
distribution channel and region. The regional introductory section
provides key insights on the market dynamics for each region. The
section is mainly designed to provide current scenario of the
anticancer drugs market and forecast for 20182026. The representative
market participants section gives the list of companies operating in
each region, competitive landscape and intensity map of their
presence in each region.
To arrive at the market value, we have used our in-house proprietary model to estimate the anticancer drugs market value. We have adopted bottom-up approach to forecast the anticancer drugs market. Weighted average selling price is considered to estimate the market value of various drug class mentioned in the scope of the report. The country price is captured with the local currency. The local currency figures are then converted to US$ to offer forecasts in a consistent currency standard. Furthermore, PMR has also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of a country. Prices considered in the models are standardized based on the average of various drug class.
The revenue forecast presented in the report provides total revenue of the currently available anticancer drugs over 20132026. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.
In the next section of the report, the Competitive Landscape is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. The market structure analysis provides tier-wise breakdown of the total market revenue. The section also provides company share analysis and brand share analysis for the key market players. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players operating in the global anticancer drugs market are also provided in the report, which highlight company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.
To arrive at the market value, we have used our in-house proprietary model to estimate the anticancer drugs market value. We have adopted bottom-up approach to forecast the anticancer drugs market. Weighted average selling price is considered to estimate the market value of various drug class mentioned in the scope of the report. The country price is captured with the local currency. The local currency figures are then converted to US$ to offer forecasts in a consistent currency standard. Furthermore, PMR has also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of a country. Prices considered in the models are standardized based on the average of various drug class.
The revenue forecast presented in the report provides total revenue of the currently available anticancer drugs over 20132026. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.
In the next section of the report, the Competitive Landscape is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. The market structure analysis provides tier-wise breakdown of the total market revenue. The section also provides company share analysis and brand share analysis for the key market players. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players operating in the global anticancer drugs market are also provided in the report, which highlight company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.
Continue.....
– More
Clear Details get Full Table of Contents_
https://www.researchmoz.us/global-market-study-on-anticancer-drugs-targeted-therapy-drug-class-anticipated-to-exhibit-highest-revenue-contribution-through-2026-report.html/toc
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research
Coordinators.
--Researchmoz Global Pvt. Ltd.--
--Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment